The method we use to diagnose Nocardia brasiliensis infections is a combination of laboratory tests and cultures of secretion from ruptured abscesses, which is less precise and faster than molecular methods, such as 16S rRNA, hsp65, and secA1 gene sequencing, it makes us significantly late in the medications for Nocardia brasiliensis. This evidence concerns the gene HSPD1 and abscess.